Blood glucose control in critically ill patients: do we know whom and how intensively to treat?

Abstract

With recent available data, with exception of (cardiac) surgery patients, we can’t say that TGC generally decreased both mortality and morbidity in ICU patients. Based on clinical and experimental studies we can expect that TGC decreases onset of several complications associated with critical illness – al least neurological (polyneuropathies) and infectious, and that generally preserves central and peripheral nerve system from secondary insults.

We know the target group are nondiabetics or not know yet diabetics, who are not adapted to high and fast hyperglycemia.